Pricing Log in Create free account

Biodesix, Inc. (BDSX) vs Castle Biosciences, Inc. (CSTL)

Biodesix, Inc. and Castle Biosciences, Inc. are both Diagnostics & Research companies. Castle Biosciences, Inc. is the larger, with a market value of $1.0B against $209.3M — 5.0× the size. Biodesix, Inc. grew revenue faster over the last twelve months: 31.2% against 9.78%. Castle Biosciences, Inc. has the higher net margin (−6.10% vs −25.7%) and the higher return on invested capital (−3.63% vs −44.8%). Across the 18 metrics below, Castle Biosciences, Inc. leads on 14 and Biodesix, Inc. on 4.

Valuation

Metric BDSX CSTL Diagnostics & Research median
P/E n/m n/m 34.52
P/S 2.01 2.77 4.24
P/B 24.38 2.19 3.42
Price to free cash flow n/m 262.33 33.51
EV/EBITDA n/m n/m 23.44
EV/Sales 2.19 2.10 5.18
Earnings yield (13.91%) (2.25%) (1.50%)
Free cash flow yield (9.11%) 0.38% 0.00%

Profitability

Metric BDSX CSTL Diagnostics & Research median
Gross margin 0.00% 77.07% 48.32%
Operating margin (18.69%) (7.43%) (5.68%)
Net margin (25.74%) (6.10%) (4.10%)
Free cash flow margin (18.30%) 1.06% 0.00%
Return on equity (778.89%) (4.87%) 0.00%
Return on assets (29.65%) (4.03%) (6.05%)
Return on invested capital (44.84%) (3.63%) 0.00%

Growth

Metric BDSX CSTL Diagnostics & Research median
Revenue growth (TTM) 31.23% 9.78% 8.99%
EPS growth (last fiscal year) 29.24% (233.87%) 20.36%
Revenue growth, 5-year CAGR 14.20% 40.60% 7.30%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BDSX CSTL Diagnostics & Research median
Debt to equity 5.43 0.01 0.01
Current ratio 2.96 5.28 2.27
Net debt to EBITDA (1.36) 46.20 0.68

Dividend

Metric BDSX CSTL Diagnostics & Research median
Dividend yield — — 0.67%
Payout ratio — — 0.20

Size

Metric BDSX CSTL Diagnostics & Research median
Market cap 209.33m 1.04b 2.22b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack